CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

SARS-CoV-2 antibody testingWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation

Correlated Drug Terms (1)

Name (Synonyms) Correlation
drug549 COVID-19 Specific T Cell derived exosomes (CSTC-Exo) Wiki 1.00

Correlated MeSH Terms (3)

Name (Synonyms) Correlation
D011014 Pneumonia NIH 0.06
D045169 Severe Acute Respiratory Syndrome NIH 0.05
D018352 Coronavirus Infections NIH 0.04

Correlated HPO Terms (1)

Name (Synonyms) Correlation
HP:0002090 Pneumonia HPO 0.06

There is one clinical trial.

Clinical Trials

1 SARS-CoV-2 Specific Immune Responses in Hospitalized Persons Under Investigation (PUIs) With Negative Nasopharyngeal PCR Swabs - The COVID-19 PUI Reality Check (CPRC) Study

This study compares SARS-CoV-2 immune responses in high pretest probability swab negative hospitalized PUI patients vs. low pretest probability swab negative hospitalized APS (Asymptomatic Persons being Screened) patients to try to understand the appropriateness and safety of clinical decisions made in these patient populations based on swab results.

NCT04474288 Covid19 Immunology Diagnostic Test: SARS-CoV-2 antibody testing

Primary Outcomes

Description: Qualitative seroconversion response rates (RR) in NP SARS-CoV-2 PCR swab negative PUI vs. swab negative APS patients will be compared as the primary outcome measurement.

Measure: SARS-CoV-2 IgG

Time: 120 days

Secondary Outcomes

Description: mRNA gene expression by RNAseq from whole blood collected into PAXGene RNA tubes

Measure: host immune response

Time: 120 Days

Description: identification of a signature of differentially expressed host genes or antigen/epitope specific antibody or cellular responses.

Measure: pathogen protein expression

Time: 120 days

No related HPO nodes (Using clinical trials)